Philippe Marlière, Cofounder and Project Initiator, is the President of the Scientific Board, which consists of the following leading scientists:
Dr. Bernard Badet heads a research group at the Institut de Chimie des Substances Naturelles (Gif-sur-Yvette, France) that is interested in the understanding of the enzyme mechanism towards the development of chemical tools for diagnostic and therapeutic purposes.
Prof. Dr. Donald Hilvert heads a research group at the ETH Zürich (Zürich, Switzerland). His research program focuses on understanding how enzymes work and evolve and on mimicking the properties of these remarkable catalysts in the laboratory.
Pr. Jean-Marc Paris led the R&D division responsible for antibiotic discovery at Rhône Poulenc Rorer before joining Rhodia, where he worked as Scientific Director for organic chemistry and biotechnologies. He is honorary Professor at the Ecole Nationale Supérieure de Chimie de Paris.
Prof. Dieter Söll heads a research laboratory at Yale University in New Haven (Connecticut, USA), investigating the biocatalytic and evolutionary basis of protein biosynthesis. Prof. Söll is a member of the US Academy of Sciences.
Dr. Jean Weissenbach is the Director of Genoscope, the French genome sequencing center, which he founded in 1997. Now part of the Genomics Institute of the CEA, Genoscope is searching new enzyme activities using genomics and large scale experimentation. Dr. Weissenbach is a member of the French Academy of Sciences.
